GBLX OTC
GB Sciences, Inc.
1W: -50.0%
1M: -66.7%
3M: -66.7%
YTD: -80.0%
1Y: -50.0%
3Y: -98.9%
5Y: -99.7%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$0.0M
52W Range0.0001-0.50015
Volume31,000
Avg Volume53,783
Beta9.64
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOAndrea Small-Howard
Employees2
SectorHealthcare
IndustryBiotechnology
IPO Date2008-05-12
Websitegbsciences.com
9205 W. Russell Road
Las Vegas, NV 89148
US
Las Vegas, NV 89148
US
866 721 0297
About GB Sciences, Inc.
Operating across North America and Europe, GB Sciences, Inc. is dedicated to the research and development of plant-based pharmaceuticals. The company specializes in crafting cannabinoid-inspired medications and complex therapeutic formulations intended for the prescription drug market. Its extensive intellectual property portfolio addresses a variety of medical conditions, with programs currently in pre-clinical animal stages. These include initiatives for Parkinson's disease, neuropathic and chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular ailments. Formed in 2001 and headquartered in Las Vegas, Nevada, the company was formerly known as Growblox Sciences, Inc. before rebranding in October 2016.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| POSS JOHN C | P-Purchase | 3,615 | $0.41 | 2018-07-11 |
| POSS JOHN C | P-Purchase | 11,915 | $0.41 | 2018-07-11 |
| POSS JOHN C | P-Purchase | 20,000 | $0.41 | 2018-07-11 |
| POSS JOHN C | P-Purchase | 1,250 | $0.41 | 2018-07-11 |
| POSS JOHN C | P-Purchase | 30,000 | $0.41 | 2018-07-11 |